[Image: masthead]

24-HOUR MH HOTLINE

800-644-9737

FOR EMERGENCIES ONLY

24-HOUR MH HOTLINE: 800-644-9737
FOR EMERGENCIES ONLY

NMS Program

Neuroleptic Malignant Syndrome

An Online Presentation on NMS

Presented by:
Stanley N. Caroff, M.D.
University of Pennsylvania
Department of Veterans Affairs Medical Center
Philadelphia, Pennsylvania

CONTRIBUTING FACULTY:

Sanjay Gupta, MD , Olean General Hospital; SUNY at Buffalo School of Medicine and Biomedical Sciences; SUNY Upstate Medical University, Syracuse, NY

Ronald J. Gurrera, MD , Harvard University, Boston VA Healthcare System

James L. Levenson, MD , Virginia Commonwealth University

Stanley N. Caroff, M.D.

 

INSTRUCTOR PROFILE:

Dr. Caroff is certified by the American Board of Psychiatry and Neurology, and is a Distinguished Fellow of the American Psychiatric Association.  He is the recipient of several awards for excellence in teaching. Presently, he is Professor of Psychiatry at the University of Pennsylvania, and Chief of the Inpatient Psychiatric Service at the Department of Veterans Affairs Medical Center in Philadelphia.  He also serves as Director of the Neuroleptic Malignant Syndrome Information Service, and is a member of the Board of Directors of the Malignant Hyperthermia Association of the United States.  He is recognized internationally as an expert in the study of neuroleptic malignant syndrome and related hyperthermic and neurologic disorders in psychiatry.

PROGRAM BACKGROUND:

This program is to provide information on NMS diagnosis and treatment based on the most current research.  It includes historical information on the recognition and diagnosis of NMS, develops strategies for the treatment of NMS and covers the differential diagnosis by an expert speaking in the field of drug-induced heat-related disorders.

TARGET AUDIENCE:

Psychiatrists, psychologists, emergency room doctors, internists, and other medical professionals.

GOAL: 

The goal of this activity is to educate healthcare professionals on the diagnostic issues and recommended treatment and management of neuroleptic malignant syndrome.

OBJECTIVES:

  1. The participant will recognize the clinical signs of NMS associated with typical and atypical antipsychotics to help determine a diagnosis
  2. The participant will be able to discuss risk factors and the changing epidemiology of NMS.
  3. The participant will identify and apply the differential diagnosis of NMS
  4. The participant will employ strategies for the treatment of NMS

OUTCOMES

  • By recognizing the clinical signs of NMS, associated with typical and atypical antipsychotics, physicians and nurses can avert serious morbidity or mortality in psychiatric patients.
  • Participants will develop an understanding of strategies for the treatment of NMS, resulting in an improved patient health status.
  • Knowing the differential diagnosis of NMS will enable physicians to treat with a more successful outcome.

ACCREDITATION STATEMENTS:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of SUNY Upstate Medical University and Neuroleptic Malignant Syndrome Information Service (NMSIS).  SUNY Upstate Medical University is accredited by the ACCME to provide continuing medical education for physicians.

DISCLOSURES:

Stanley N. Caroff, MD, is a Professor of Psychiatry at the University of Pennsylvania and Chief of the Inpatient Psychiatric Service at the Department of the Veterans Affairs Medical Center in Philadelphia.  Dr. Caroff has received support for other projects from Pfizer and Bristol-Myers Squibb and is a consultant for Solvay Pharmaceuticals and may discuss off-label use as well as investigational uses of pharmaceutical products during his presentation.

COMMERCIAL SUPPORT:  

There is no commercial support for this activity.

SPONSORS:

This program is sponsored by SUNY Upstate Medical University, College of Medicine, Continuing Medical Education and the Neuroleptic Malignant Syndrome Information Service (NMSIS).

PROGRAM RELEASED:

December 1, 2006 – December 1, 2008

INSTRUCTIONS FOR COURSE:

The program may be advanced or brought to a previous page manually by clicking on the forward and back arrows. The presentation is free of charge, but people can pay for CME credit if they're willing to take a test. Call (888) 667-8367 if interested.

Presentation opens in a pop-up window.
If you have a pop-up blocker, please disable it for this page.

MINIMUM HARDWARE/SOFTWARE REQUIREMENTS:  

Any computer hardware running a standard web browser, with Flash Player.

The mission of MHAUS is to promote optimum care and
scientific understanding of MH and related disorders.